Seoul National University Bundang Hospital
Gyeonggi-do, Seongnam-si, Gyeonggi-do, 463-707, South Korea
NCT Number: NCT04483050
The Clinical Effect of Hip Protection Orthosis for the Hip Protection of Hip Dislocation in Patients With Severe Neuromuscular Disease
Looking for future studies?
Notify Me1 year–15 year
All sexes
Interventional
Not applicable
Gyeonggi-do, Seongnam-si, Gyeonggi-do, 463-707, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Experimental group would wear hip protection orthosis over 12 hours a day for 1 year.
Time frame: 6 months
Hip AP radiography
Time frame: 6 months
using radiography, expressed by degree from 0' to 180'. The closer to 0', the better the value.
Time frame: 6 months
Using goniometer, measure the hip and knee abduction and flexion angle expressed by degree from 0' to 180'. The closer to 180', the better the value.
Time frame: 6 months
measure the pain expressed by score from 0 to 10. The closer to 10, the higher the pain.
Time frame: immediately after wearing orthosis
measure the satisfaction about hip protection orthosis expressed by score from 0 to 5. The closer to 5, the higher the satisfaction.
Time frame: 6 months
measure the quality of life expressed by score from 0 to 100. The higher the quality of life.
Seoul National University Hospital
Other
The Clinical Effect of Hip Protection Orthosis for the Hip Protection of Hip Dislocation in Patients With Severe Neuromuscular Disease, Open Label, Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07729800
Brain Damage, Chronic, Brain Diseases
Lahore, Pakistan
View Trial DetailsNCT07683338
Bilateral Spastic Cerebral Palsy, Brain Damage, Chronic
Faisalabad, Punjab Province, Pakistan
View Trial DetailsNCT07706517
Brain Damage, Chronic, Brain Diseases
Saint-Etienne, France
View Trial DetailsNCT05791877
Brain Damage, Chronic, Brain Diseases
Wilmington, Delaware, United States
View Trial Details